Skip to Main Content

Paper Details

Phase-III Clinical Trial of Fluorine-18 Flurpiridaz Positron Emission Tomography for Evaluation of Coronary Artery Disease.
J Am Coll Cardiol
53
2020
  • 1 - 1

Datasets